Summary & Overview
HCPCS C8012: Hypoglossal Nerve Neurostimulator Revision or Replacement
HCPCS Level II code C8012 denotes the surgical revision or replacement of hypoglossal nerve neurostimulator electrode arrays and receiver. This code is used to capture services related to management of implanted hypoglossal nerve stimulation systems, a targeted therapy for obstructive sleep apnea and other neurological conditions where hypoglossal nerve stimulation is indicated. Nationally, accurate coding for device revisions is important for tracking utilization, device performance issues, and payment consistency across payers.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what C8012 represents, typical sites of service, and the clinical context for why revisions or replacements occur. The publication summarizes benchmark considerations and payer coverage patterns where available, clarifies coding scope, and highlights policy updates or documentation expectations relevant to implanted neurostimulator component procedures.
This resource is intended for billing professionals, clinicians involved in device management, and policy analysts seeking a national-level briefing on coding and coverage considerations for hypoglossal nerve neurostimulator revision or replacement services.
Billing Code Overview
HCPCS Level II code C8012 describes revision or replacement of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver. This service involves surgical revision or replacement of implanted neurostimulation hardware targeting the hypoglossal nerve, typically performed to address device malfunction, lead migration, infection, or to upgrade components.
-
Service type: Surgical revision or replacement of implanted neurostimulation system components
-
Typical site of service: Hospital operating room or ambulatory surgery center
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with implanted hypoglossal nerve neurostimulation system for obstructive sleep apnea presents with recurrent device malfunction and lead migration, causing loss of therapeutic stimulation and intermittent tongue weakness. The patient is evaluated by the implanting otolaryngologist and sleep medicine team. Preoperative assessment includes device interrogation, polysomnography review, imaging (neck and chest radiographs or CT) to localize the electrode array and receiver, routine labs, and anesthesia assessment. The procedure performed is revision or replacement of the hypoglossal nerve(s) neurostimulator electrode array(s) and receiver (C8012). In the operating room under general anesthesia, the surgeon exposes the existing implant pocket, disconnects and removes malfunctioning electrode leads and receiver as needed, replaces or repositions electrode arrays along the hypoglossal nerve, tests stimulation thresholds intraoperatively, secures the new receiver in the subcutaneous pocket, and closes wounds. Postoperative care includes device reprogramming, wound checks, and follow-up sleep testing to confirm therapeutic effect. Typical sites of service are an inpatient or outpatient hospital operating room or ambulatory surgery center depending on comorbidity and facility capabilities.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated Evaluation and Management Service by the Same Physician During a Postoperative Period |